Park Ha Biological Technology is trading at $2.12 (-8.61%) in pre-market; its cause remains unclear.
- No verified October 26 company announcement or new catalyst explaining the pre-market decline was found.
- Search results included a class-action notice updated October 26, but its underlying press release is dated July 30; it does not establish a new event driving the move.
- Broader U.S. market indicators are higher, so the supplied context does not support attributing this decline to broad market weakness.